Clinical Trials Finder hero image

Clinical Trials Finder

Clinical trials may offer you additional treatment options in addition to standard treatment options already available and approved to treat your cancer.

A common misconception is that clinical trials are only for people who have tried everything else and are out of options. In fact, a clinical trial may be the best option to treat your cancer at any stage of your cancer journey.

Not every clinical trial is available at every cancer center. Finding a clinical trial that may be an option for you can be difficult to navigate on your own. The KCA is proud to offer our new Clinical Trial Finder that may provide options for you close to home or anywhere in the United States. If a clinical trial that fits your cancer isn’t available now, one may be available in the future, so check back often. Talk to your doctor about clinical trials, including any that you find using the tool below.

The Clinical Trial Finder is intended for patients and caregivers for educational purposes only. Only your doctor can best advise if a clinical trial is appropriate for you. This tool uses information from clinicaltrials.gov and is updated monthly. KCA is not responsible for information provided to clinicaltrials.gov; complete trial information can be found on that website.

Find a Clinical Trial

Trials (167 Results)

Featured Trials

Title Lead Sponsor
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer Pfizer
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma Arcus Biosciences, Inc.

Trials

Title Lead Sponsor
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome Ohio State University
Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) National Cancer Institute (NCI)
Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE) M.D. Anderson Cancer Center
Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma M.D. Anderson Cancer Center
Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation Thomas Jefferson University
International PPB/DICER1 Registry Children’s Hospitals and Clinics of Minnesota
Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C… National Cancer Institute (NCI)

Last updated: September 4, 2026

Keep Learning:

The Kidney Cancer Association provides educational literature for anyone impacted by kidney cancer.

Request your free copy today